How funding from big pharma affects trial results

By Lucy Cormack
Updated March 8 2017 - 1:14pm, first published February 21 2017 - 3:31pm
A new study says drug industry-sponsored studies are more likely to deliver results and conclusions that favoured the sponsor. Photo: Erin Jonasson
A new study says drug industry-sponsored studies are more likely to deliver results and conclusions that favoured the sponsor. Photo: Erin Jonasson
A recent Cochrane review has revealed "definitive evidence" that pharmaceutical industry funding of drug studies biases results. Photo: Louie Douvis
A recent Cochrane review has revealed "definitive evidence" that pharmaceutical industry funding of drug studies biases results. Photo: Louie Douvis
Generic and non generic prescription prescription pharmaceuticals at John Bell Chemist, Woollarah. Pills, pharmacist, doctor, medical, health. Sunday 9th January 2011 AFR photo Louie Douvis job# 140519 Photo: Louie Douvis
Generic and non generic prescription prescription pharmaceuticals at John Bell Chemist, Woollarah. Pills, pharmacist, doctor, medical, health. Sunday 9th January 2011 AFR photo Louie Douvis job# 140519 Photo: Louie Douvis

Drug and device trial studies that are sponsored by the pharmaceutical industry are more likely to reveal statistical results and conclusions that favour a sponsor's product, a new Cochrane Library review has found.

Get the latest St George news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.